CTMX

CytomX Therapeutics Inc

Jun 12 • 04:00PM ET

3.01

+0.03 1.01 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA RCUS TNGX CGON NUVL KYMR RYTM BMRN INCY KRYS

| Held by: VTI XBI VXF IBB VHT FDM CANC DFAS IDNA ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	20.48%	Shs Outstand	217.69M	Perf Week	0.33%
Market Cap	655.29M	Forward P/E	-	EPS next Y	-0.50	Insider Trans	-0.43%	Shs Float	173.12M	Perf Month	-20.58%
Enterprise Value	311.44M	PEG	-	EPS next Q	-0.08	Inst Own	81.45%	Short Float	16.59%	Perf Quarter	-35.68%
Income	-62.14M	P/S	18.44	EPS this Y	-177.09%	Inst Trans	24.96%	Short Ratio	4.17	Perf Half Y	-22.82%
Sales	35.54M	P/B	2.05	EPS next Y	-19.39%	ROA	-25.83%	Short Interest	28.72M	Perf YTD	-29.34%
Book/sh	1.47	P/C	1.89	EPS next 5Y	-	ROE	-34.29%	52W High	8.21 -63.34%	Perf Year	0.67%
Cash/sh	1.59	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-18.48%	52W Low	1.72 75.00%	Perf 3Y	79.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	96.51%	Volatility	5.05% 5.18%	Perf 5Y	-57.96%
Dividend TTM	-	EV/Sales	8.76	EPS Y/Y TTM	-173.33%	Oper. Margin	-182.20%	ATR (14)	0.19	Perf 10Y	-70.40%
Dividend Ex-Date	-	Quick Ratio	10.38	Sales Y/Y TTM	-75.91%	Profit Margin	-174.84%	RSI (14)	30.68	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	10.38	EPS Q/Q	-138.13%	SMA20	-10.99%	Beta	2.13	Target Price	12.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-79.85%	SMA50	-23.46%	Rel Volume	0.30	Prev Close	2.98
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	-25.47%	Avg Volume	6.88M	Price	3.01
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	2,049,900	Change	1.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)